Restricted accessLetterFirst published online 2009-12
Cardiovascular and Cerebrovascular Events in Temporal Relationship to Intravenous Glucocorticoid Pulse Therapy in Patients with Severe Endocrine Ophthalmopathy
Kauppinen-MäkelinR, KarmaA, LeinonenE, LöyttyniemiE, SalonenO, SaneT, SetäläK, ViikariJ, HeufelderA, VälimäkiM. 2002. High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid-associated ophthalmopathy. Acta Ophthalmol Scand, 80:316–321.
4.
MarcocciC, BartalenaL, TandaML, ManettiL, Dell'untoE, RocchiR, BarbesinoG, MazziB, BartolomeiMP, LepriP, CarteiF, NardiM, PincheraA. 2001. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. J Clin Endocrinol Metab, 86:3562–3567.
KahalyJ, PitzS, HommelG, DittmarM. 2005. Randomized, single blind trial of intravenous versus oral steroid monotherapy in Grave's orbitopathy. J Clin Endocrinol Metab, 90:5234–5240.
7.
AktaranS, AkarsuE, ErbagciI, ArazM, OkumusS, KartalM. 2007. Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy. Int J Clin Pract, 61:45–51.
8.
WeisselM, HauffW. 2000. Fatal liver failure after high-dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease. Thyroid, 10:521.
9.
MarinoM, MorabitoM, BrunettoMR, BartalenaL, PincheraA, MarcocciC. 2004. Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves' Ophthalmopathy. Thyroid, 14:403–406.
10.
Le MoliR, BaldeschiL, SaeedP, RegensburgN, MouritsMP, WiersingaWM. 2007. Determinants of liver damage associated intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy. Thyroid, 17:357–362.
11.
OweckiM, SowinskiJ. 2006. Cute myocardial infarction during high-dose methylprednisolone therapy for Graves' ophthalmopathy. Pharm World Sci, 28:73–75.
12.
BartalenaL, BaldeschiL, DickinsonAJ, EcksteinA, Kendall-TaylorP, MarcocciC, MouritsMP, PerrosP, BoboridisK, BoschiA, CurròN, DaumerieC, KahalyJ, KrassasG, LaneCM, LazarusJH, MarinòM, NardiM, NeohC, OrgiazziJ, PearceS, PincheraA, PitzS, SalviM, SivelliP, StahlM, von ArxG, WiersingaWM. 2008. Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. Thyroid, 18:273–285.
